XML 23 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Statement of Cash Flows [Abstract]    
Net income (loss) $ (14,205,925) $ 88,930,311
Net income from discontinued operation (2,388,900) 119,206,123
Net loss from continuing operations (11,817,025) (30,275,812)
Adjustments to reconcile net income to net cash provided by operating activities    
Depreciation 57,563 1,461
Amortization 5,340 80,733
Provision for doubtful debts (1,823) 3,569,952
Impairment of intangible assets   1,759,059
Impairment of intangible goodwill 781,733  
Impairment of long term investment 12,250,000
Share-based payments 6,381,180 7,131,000
Loss on debt settlement and conversion 2,599,304
Interest expenses related to convertible note 99,858
Changes in operating assets and liabilities    
Accounts receivable (7,693,914)
Inventory   3,594
Other receivables (1,815,109) (249,073)
Advances to suppliers and other current assets (2,905,416) (24,583)
Accounts payable 3 (1,215)
Accrued expenses (954,368) 835,986
Advances from customers (26,069) (319,359)
Proceeds from amounts due from related parties, net 438,240 599,012
Repayment of amounts due to related parties, net (1,187,875) (35,868)
Net Cash Used in Operating Activities – Continued Operations (18,737,540) (1,975,951)
Net Cash Used in Operating Activities – Discontinued Operations 1,363,946 (5,249,329)
CASH FLOWS FROM INVESTING ACTIVITIES    
Additions to property, plant and equipment (3,167,126) (2,944)
Additions to loan receivables (6,000,000)
Payment for available-for-sale securities (2,191,294)
Acquisition of a subsidiary, net of cash 275,623
Disposal of a subsidiary, net of cash (59,255)
Purchase of intangible assets (38,935)  
Net Cash Used in Investing Activities from Continued Operations (11,180,987) (2,944)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from the issuance of common stock, net of issuance costs 69,430,439 10,256,309
Proceeds from loan payable 1,007,517
Repayment of loans 74,481
Proceeds from secured convertible promissory note 6,086,535
Repayment of convertible note payables (1,163,146)
Net cash provided by financing activities 69,274,810 16,417,325
Effect of change in exchange rate 127,976 75,081
NET INCREASE IN CASH AND CASH EQUIVALENTS 40,848,205 9,264,182
Cash and cash equivalents, beginning of period 9,425,312 526,844
Cash and cash equivalents, end of period 50,273,517 9,791,026
Less: Cash and cash equivalents from the discontinued operations, end of period (365,714)
Cash and cash equivalents, from the continuing operations end of period 50,273,517 9,425,312
SUPPLEMENTARY DISCLOSURE OF SIGNIFICANT NON-CASH TRANSACTION    
Issuance of common stocks (Note 10) 11,220,779
Deferred liabilities (Note 10) 7,124,304
Debt settlement by issuance of common stock   4,961,000
Issuance of common stocks for conversion of debts $ 700,236